This is a Validated Antibody Database (VAD) review about human EIF3I, based on 2 published articles (read how Labome selects the articles), using EIF3I antibody in all methods. It is aimed to help Labome visitors find the most suited EIF3I antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
EIF3I synonym: EIF3S2; PRO2242; TRIP-1; TRIP1; eIF3-beta; eIF3-p36; eukaryotic translation initiation factor 3 subunit I; TGF-beta receptor-interacting protein 1; TGFbeta receptor-interacting protein 1; eukaryotic translation initiation factor 3 subunit 2; eukaryotic translation initiation factor 3, subunit 2 (beta, 36kD); eukaryotic translation initiation factor 3, subunit 2 beta, 36kDa

BioLegend
mouse monoclonal (17C11)
  • western blot; human; fig 1
In order to study the mechanisms by which eIF3 contributes to carcinogenesis, BioLegend EIF3I antibody (Biolegend, 646701) was used in western blot on human samples (fig 1). Nature (2015) ncbi
Sigma-Aldrich
rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 5a
Sigma-Aldrich EIF3I antibody (Sigma, HPA029939) was used in western blot on mouse samples at 1:500 (fig 5a). elife (2019) ncbi
Articles Reviewed
  1. V kovski P, Gerber M, Kelly J, Pfaender S, Ebert N, Braga Lagache S, et al. Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling. elife. 2019;8: pubmed publisher
  2. Lee A, Kranzusch P, Cate J. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015;522:111-4 pubmed publisher